Company:  PROTALIX BIOTHERAPEUTICS, ... (PLX)
Form Type:  8-K
Filing Date:  2/16/2012 
CIK:  0001006281 
Address:  2 SNUNIT ST
SCIENCE PARK, POB 455
 
City, State, Zip:  CARMIEL,  20100 
Telephone:  972-4-988-9488 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.13  
Change: 
-0.04 (-0.96%)  
Trade Time: 
04:01 PM EST  
Market Cap: 
$386.49M
Description of Business
We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx� protein expression system, or ProCellEx. Using our ProCellEx system, we are developing a pipeline of proprietary, biobetter and biosimilar versions of recombinant therapeutic proteins, based on our plant cell-based expression technology, that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action. Our initial commercial focus has been on complex therapeutic proteins, including proteins for the treatment of genetic disorders, such as Gaucher disease and Fabry disease. We believe ProCellEx will enable us to develop proprietary recombinant proteins that are therapeutically equivalent or superior to existing recombinant proteins currently marketed for the same indications.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 1.1
  EXHIBIT 5.1
  EXHIBIT 99.1
BROKERAGE PARTNERS